Why is Johnson Pharma falling/rising?

As of 15-Oct, Johnson Pharmacare Ltd is experiencing a decline in its stock price, currently at Rs. 0.63, which reflects a decrease of Rs. 0.01 or 1.56%. The stock has recently hit a new 52-week low of Rs. 0.60 and has underperformed its sector by 3.33%. Over the past two days, the stock has seen a consecutive fall, resulting in a total decline of 4.55%. Additionally, it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a bearish trend. The delivery volume has also decreased by 13.43% compared to the 5-day average, suggesting a drop in investor participation, which may further contribute to the stock's downward movement. There is no information available regarding positive or negative factors that could influence the stock.
Broader market context indicates that Johnson Pharmacare's performance has significantly lagged behind the benchmark, with a 1-week return of -13.70% compared to the Sensex's gain of 1.02%. Over the past month, the stock has declined by 19.23%, while the Sensex has remained relatively stable with a 1% increase. Year-to-date, Johnson Pharmacare has fallen by 44.74%, contrasting sharply with the Sensex's positive return of 5.72%. This stark difference in performance highlights the challenges faced by Johnson Pharmacare in the current market environment.